C10-13-苯磺酸-烷基衍生物与三乙醇胺的化合物 | 121617-08-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: C10-13-苯磺酸-烷基衍生物与三乙醇胺的化合物
• 英文名称: Triethanolammonium benzene sulfonate
• 英文别名: Einecs 260-839-5；benzenesulfonic acid;2-[bis(2-hydroxyethyl)amino]ethanol
• CAS: 121617-08-1；68411-31-4；68648-96-4；57592-59-3
• 化学式: C₆H₆O₃S*C₆H₁₅NO₃
• 分子量: 307.368
• InChiKey: AVZMHCLRAZFNHJ-UHFFFAOYSA-N

物化性质

• 沸点：
  220℃ at 101kPa
• 密度：
  1.08g/cm3 at 21℃
• LogP：
  1.5 at 23℃ and pH6-7
• 表面张力：
  32.81mN/m at 804mg/L and 25℃
• 解离常数：
  2.19 at 20℃
• 物理描述：
  Liquid

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  127
• 氢给体数：
  4
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  三乙醇胺 、 苯磺酸 反应 8.0h， 生成 C10-13-苯磺酸-烷基衍生物与三乙醇胺的化合物
  参考文献：
  名称：

  具有各种磺酸的三乙醇胺基质子离子液体：合成与性能

  摘要：

  通过质子从磺酸到三乙醇胺（TEOA）的质子转移反应，合成了十种基于三（2-羟乙基）铵（三乙醇铵）的质子离子液体（ILs）和一种熔融盐。使用前，将产生的PIL在高真空下于50°C干燥8小时。通过1 H NMR，13 C NMR，1 H / 15表征PILN NMR和FT-IR光谱法。所研究的PIL的IR和NMR谱的参数由磺酸苯环上取代基的性质决定。使用差示扫描量热法（DSC）和热重分析（TGA）研究了PIL的相行为。研究了每个PIL的电导率和电化学窗口的温度依赖性。为了研究性能，讨论了对PILs阴离子组分的取代作用。

  DOI：

  10.1016/j.molliq.2017.07.078

文献信息

• Production process of cross-linked polyaspartic acid resin
  申请人：MITSUI CHEMICALS, INC.

  公开号：EP0866084A2

  公开（公告）日：1998-09-23

  A process is disclosed for producing with good productivity a cross-linked polyaspartic acid resin having biodegradability and high water absorbency. The process features inclusion of one of the following steps: (a) a polysuccinimide, which has been brought into a dispersed state by a dispersant, and a cross-linking agent are reacted to produce the cross-linked polyaspartic acid resin; (b) imide rings of a cross-linked polysuccinimide are subjected to a hydrolysis reaction while controlling a swelling degree of a resulting gel, whereby the cross-linked polyaspartic acid resin is produced; and (c) a gel of a cross-linked polysuccinimide, which has been obtained by reacting a cross-linking agent to a solution of a polysuccinimide in an organic solvent, is disintegrated to subject imide rings of the cross-linked polysuccinimide to a hydrolysis reaction, so that the cross-linked polyaspartic acid resin is produced. The process may also include one or both of the following steps as needed: (d) a gel of the cross-linked polyaspartic acid resin is washed with water and/or a water-miscible organic solvent; and (e) the polysuccinimide is produced using a basic amino acid as a cross-linking agent.

  本发明公开了一种工艺，用于生产具有生物降解性和高吸水性的交联聚天冬氨酸树脂，生产效率高。该工艺的特点是包含以下步骤之一：(a) 通过分散剂使聚琥珀酰亚胺进入分散状态，并与交联剂反应，生成交联聚天冬氨酸树脂；(b) 将交联聚琥珀酰亚胺的酰亚胺环进行水解反应，同时控制所得凝胶的溶胀度，从而生成交联聚天冬氨酸树脂；(c) 将交联剂与聚琥珀酰亚胺在有机溶剂中的溶液反应而得到的交联聚琥珀酰亚胺凝胶分解，使交联聚琥珀酰亚胺的酰亚胺环发生水解反应，从而制得交联聚天冬氨酸树脂。根据需要，该工艺还可包括以下一个或两个步骤：(d) 用水和/或水混溶有机溶剂洗涤交联聚天冬氨酸树脂的凝胶；(e) 使用碱性氨基酸作为交联剂生产聚琥珀酰亚胺。
• Film-forming compositions and methods
  申请人：3M Innovative Properties Company

  公开号：EP1849487A2

  公开（公告）日：2007-10-31

  Film-forming compositions, as well as methods of making and using, wherein the compositions include an optional active agent, water, a surfactant, and a water-soluble or water-dispersible vinyl polymer comprising amine group-containing side-chains and a copolymerized hydrophobic monomer; wherein the amine equivalent weight of the polymer is at least about 300 grams polymer per equivalent of amine group.

  成膜组合物以及制造和使用方法，其中组合物包括任选活性剂、水、表面活性剂以及水溶性或水分散性乙烯基聚合物，该聚合物包含含胺基的侧链和共聚疏水单体；其中聚合物的胺基当量重量至少为每当量胺基约 300 克聚合物。
• Antiseptic compositions and methods
  申请人：3M Innovative Properties Company

  公开号：EP1955594A1

  公开（公告）日：2008-08-13

  The present invention relates to an antiseptic composition comprising an antimicrobial agent selected from the group consisting of I2, an iodophor, and a combination thereof, wherein the antimicrobial agent is present in an amount sufficient to provide an available iodine concentration of at least about 0.25 wt-%; a hydroxycarboxylic acid buffer in an amount in excess of 5 wt-%; and water.

  本发明涉及一种防腐组合物，该组合物包含一种选自由 I2、碘伏及其组合组成的组的抗菌剂，其中抗菌剂的用量足以提供至少约 0.25 wt-% 的可用碘浓度；一种用量超过 5 wt-% 的羟基羧酸缓冲剂；以及水。
• Ophthalmic composition
  申请人：Omnivision GmbH

  公开号：EP2452669A1

  公开（公告）日：2012-05-16

  The present invention relates to an aqueous ophthalmic composition comprising (i) a prostaglandin; and (ii) one or more anionic surfactants, characterized in that the concentration of anionic surfactant in the ophthalmic composition is from 0.001 to 1.0 g/L.

  本发明涉及一种水性眼科组合物，其中包括 (i) 前列腺素；和 (ii) 一种或多种阴离子表面活性剂、 其特征在于 眼科组合物中阴离子表面活性剂的浓度为 0.001 至 1.0 克/升。
• Composition for film formation, method of film formation, and silica-based film
  申请人：JSR CORPORATION

  公开号：US20030091838A1

  公开（公告）日：2003-05-15

  A composition for film formation which comprises: (A) a product of hydrolysis and condensation obtained by hydrolyzing and condensing at least one silane compound selected from the group consisting of compounds represented by the formula (1), compounds represented by the formula (2), and compounds represented by the formula (3) in the presence of water and an ammonium compound, and (B) an organic solvent.

  一种用于成膜的组合物，它包括 (A) 至少一种硅烷化合物的水解和缩合产物，该硅烷化合物选自由式（1）、式（2）和式（3）所代表的化合物组成的组，在水和铵化合物存在下水解和缩合得到，以及 (B) 有机溶剂。